PFAM Search:   
       by Pfam accession/ID, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  

Full view: branches of nodes matching the query are shown completely (Compact view)

(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Clan: PKinase (934)
(-)
Family: Pkinase_Tyr (229)
(-)
Gallus gallus (Chicken) (9)
2JKKA:422-676FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
2JKMA:422-676FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
2JKOA:422-676FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
2OIQB:267-516; B:267-516CRYSTAL STRUCTURE OF CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH THE CANCER DRUG IMATINIB.
2PTKA:267-516CHICKEN SRC TYROSINE KINASE
2QI8B:267-516; B:267-516CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN
2QLQB:267-516; B:267-516CRYSTAL STRUCTURE OF SRC KINASE DOMAIN WITH COVALENT INHIBITOR RL3
2QQ7B:267-516; B:267-516CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN WITH IRREVERSIBLE INHIBITOR
3LOKB:267-516; B:267-516DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR PD168393
(-)
Homo sapiens (Human) (202)
2V7AB:242-493; B:242-493CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358
3QRIB:242-493; B:242-493THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DCC-2036
3QRJB:242-493; B:242-493THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN T315I MUTANT IN COMPLEX WITH DCC-2036
3QRKA:242-493THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DP-987
2XYNC:288-539; C:288-539; C:288-539HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680
1U46B:126-385; B:126-385CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1
1U4DB:126-385; B:126-385STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE
1U54B:126-385; B:126-385CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP
2XB7A:1116-1383STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH NVP-TAE684
2XBAA:1116-1383STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PHA-E429
2YHVA:1116-1383STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE
3L9PA:1116-1383CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
3LCSA:1116-1383CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
3LCTA:1116-1383CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
2XP2A:1116-1383STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066)
2YFXA:1116-1383STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
1UWHB:456-713; B:456-713THE COMPLEX OF WILD TYPE B-RAF AND BAY439006
3PPJB:457-714; B:457-714HUMAN B-RAF KINASE IN COMPLEX WITH A FUROPYRIDINE INHIBITOR
3PPKB:457-714; B:457-714HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
3PRFB:457-714; B:457-714CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
3PRIB:457-714; B:457-714CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
3PSBB:457-714; B:457-714FURO[2,3-C]PYRIDINE-BASED INDANONE OXIMES AS POTENT AND SELECTIVE B-RAF INHIBITORS
3PSDB:457-714; B:457-714NON-OXIME PYRAZOLE BASED INHIBITORS OF B-RAF KINASE
3Q4CB:456-713; B:456-713CRYSTAL STRUCTURE OF WILD TYPE BRAF KINASE DOMAIN IN COMPLEX WITH ORGANOMETALLIC INHIBITOR CNS292
3Q96B:457-714; B:457-714B-RAF KINASE DOMAIN IN COMPLEX WITH A TETRAHYDRONAPHTHALENE INHIBITOR
1K2PB:402-651; B:402-651CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE DOMAIN
3K54A:402-651STRUCTURES OF HUMAN BRUTON'S TYROSINE KINASE IN ACTIVE AND INACTIVE CONFORMATIONS SUGGESTS A MECHANISM OF ACTIVATION FOR TEC FAMILY KINASES.
3OCSA:402-651CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI1746
3OCTA:402-651CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE MUTANT V555R IN COMPLEX WITH DASATINIB
3P08B:402-651; B:402-651CRYSTAL STRUCTURE OF THE HUMAN BTK KINASE DOMAIN
3PIXA:402-651CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-ISOPROPYL-7-(4-METHYL-PIPERAZIN-1-YL)-4-(5-METHYL-2H-PYRAZOL-3-YLAMINO)-2H-PHTHALAZIN-1-ONE
3PIYA:402-651CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH R406
3PIZA:402-651CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH (5-AMINO-1-O-TOLYL-1H-PYRAZOL-4-YL)-[3-(1-METHANESULFONYL-PIPERIDIN-4-YL)-PHENYL]-METHANONE
3PJ1A:402-651CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 3-(2,6-DICHLORO-PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-3,4-DIHYDRO-1H-PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE
3PJ2A:402-651CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-6-(4-FLUORO-PHENOXY)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3PJ3A:402-651CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-METHYL-5-[(E)-(3-PHENYL-ACRYLOYL)AMINO]-N-(2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-BENZAMIDE
2OGVA:582-910CRYSTAL STRUCTURE OF THE AUTOINHIBITED HUMAN C-FMS KINASE DOMAIN
3LCDA:582-910INHIBITOR BOUND TO A DFG-IN STRUCTURE OF THE KINASE DOMAIN OF CSF-1R
3LCOA:582-910INHIBITOR BOUND TO A DFG-OUT STRUCTURE OF THE KINASE DOMAIN OF CSF-1R
1M14A:688-944TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR
1M17A:688-944EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN WITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB
1XKKA:712-968EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR-GW572016
1Z9IA:44-53A STRUCTURAL MODEL FOR THE MEMBRANE-BOUND FORM OF THE JUXTAMEMBRANE DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR
2JITB:712-968; B:712-968CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION
2JIUB:712-968; B:712-968CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788
2JIVB:712-968; B:712-968CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPEX WITH HKI-272
2RF9B:688-944; B:688-944CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
2RFDB:688-944; B:688-944CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
2RFED:688-944; D:688-944; D:688-944; D:688-944CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
2RGPA:712-968STRUCTURE OF EGFR IN COMPLEX WITH HYDRAZONE, A POTENT DUAL INHIBITOR
3LZBD:688-944; D:688-944; D:688-944; D:688-944EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[2,1-B]THIAZOLE INHIBITOR
3POZA:712-968EGFR KINASE DOMAIN COMPLEXED WITH TAK-285
1MQBB:613-871; B:613-871CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
2QO2A:621-878HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, APO STRUCTURE
2QO7A:621-878HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, AMP-PNP BOUND
2QO9A:621-878HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, PHOSPHORYLATED, AMP-PNP BOUND
2QOBA:621-878HUMAN EPHA3 KINASE DOMAIN, BASE STRUCTURE
2QOCA:621-878HUMAN EPHA3 KINASE DOMAIN, PHOSPHORYLATED, AMP-PNP BOUND STRUCTURE
2QODA:621-878HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y602F MUTANT
2QOFA:621-878HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F MUTANT
2QOKA:621-878HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:S768A TRIPLE MUTANT
2QONA:621-878HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742A TRIPLE MUTANT
2QOOA:621-878HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742F TRIPLE MUTANT
2QOQA:621-878HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, BASE, AMP-PNP BOUND STRUCTURE
2R2PA:675-932KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5)
2REIA:633-890KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7)
3KULB:635-892; B:635-892KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8)
2VWUA:615-874EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWVA:615-874EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWWA:615-874EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWXA:615-874EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWZA:615-874EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VX0A:615-874EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VX1A:615-874EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2X9FA:615-874EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2XVDA:615-874EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
3PP0B:720-976; B:720-976CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN HER2 (ERBB2).
3KEXB:690-946; B:690-946CRYSTAL STRUCTURE OF THE CATALYTICALLY INACTIVE KINASE DOMAIN OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)
3LMGB:690-946; B:690-946CRYSTAL STRUCTURE OF THE ERBB3 KINASE DOMAIN IN COMPLEX WITH AMP-PNP
2R4BB:718-974; B:718-974ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR
1MP8A:422-676CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE (FAK)
3JS2B:478-754; B:478-754CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID
3KXXD:478-754; D:478-754; D:478-754; D:478-754STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
3KY2B:478-754; B:478-754CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN
3RHXB:478-754; B:478-754CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR1 KINASE IN COMPLEX WITH ARQ 069
1OECA:481-757FGFR2 KINASE DOMAIN
2PSQB:481-757; B:481-757CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN
2PVFA:481-757CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND SUBSTRATE PEPTIDE
2PVYD:481-757; D:481-757; D:481-757; D:481-757CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
2PWLB:481-757; B:481-757CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME.
2PY3B:481-757; B:481-757CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2PZ5B:481-757; B:481-757CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2PZPB:481-757; B:481-757CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME
2PZRB:481-757; B:481-757CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2Q0BB:481-757; B:481-757CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
3RI1B:481-757; B:481-757CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR2 KINASE IN COMPLEX WITH ARQ 069
1RJBA:610-943CRYSTAL STRUCTURE OF FLT3
1QCFA:267-516CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITOR
1JQHC:999-1266; C:999-1266; C:999-1266IGF-1 RECEPTOR KINASE DOMAIN
1K3AA:969-1236STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE
1M7NB:996-1263; B:996-1263CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN
1P4OB:969-1236; B:969-1236STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION.
2OJ9A:969-1236STRUCTURE OF IGF-1R KINASE DOMAIN COMPLEXED WITH A BENZIMIDAZOLE INHIBITOR
2ZM3D:999-1266; D:999-1266; D:999-1266; D:999-1266COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
3LVPD:999-1266; D:999-1266; D:999-1266; D:999-1266CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR
3LW0D:999-1266; D:999-1266; D:999-1266; D:999-1266IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1
3NW5A:969-1236CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (11B)
3NW6A:969-1236CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (11A)
3NW7A:969-1236CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (34)
3O23A:999-1266HUMAN UNPHOSPHORYLATED IGF1-R KINASE DOMAIN IN COMPLEX WITH AN HYDANTOIN INHIBITOR
3QQUD:996-1263; D:996-1263; D:996-1263; D:996-1263COCRYSTAL STRUCTURE OF UNPHOSPHORYLATED IGF WITH PYRIMIDINE 8
3KMUA:193-446CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (APO)
3KMWA:193-446CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MGATP)
3REPA:193-446CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MNATP)
1P14A:996-1263CRYSTAL STRUCTURE OF A CATALYTIC-LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
1RQQB:996-1263; B:996-1263CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS
2Z8CA:996-1263PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN-2-YL]AMINO}PHENYL)ACETIC ACID
1SM2B:363-612; B:363-612CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1SNUB:363-612; B:363-612CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1SNXB:363-612; B:363-612CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
3MIYB:363-612; B:363-612X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH SUNITINIB
3MJ1A:363-612X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR RO5191614
3MJ2A:363-612X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR BMS-509744
3QGWB:363-612; B:363-612CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR
3QGYB:363-612; B:363-612CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX
2W1IB:849-1123; B:849-1123STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2XA4B:849-1123; B:849-1123INHIBITORS OF JAK2 KINASE DOMAIN
3JY9A:849-1123JANUS KINASE 2 INHIBITORS
3KCKA:849-1123A NOVEL CHEMOTYPE OF KINASE INHIBITORS
3KRRA:849-1123CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT QUINOXALINE ATP SITE INHIBITOR
3LPBB:849-1123; B:849-1123CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT 2,8-DIARYL-QUINOXALINE INHIBITOR
3Q32B:849-1123; B:849-1123STRUCTURE OF JANUS KINASE 2 WITH A PYRROLOTRIAZINE INHIBITOR
1YVJA:822-1095CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE
3LXKA:822-1095STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
3LXLA:822-1095STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
3PJCA:822-1095CRYSTAL STRUCTURE OF JAK3 COMPLEXED WITH A POTENT ATP SITE INHIBITOR SHOWING HIGH SELECTIVITY WITHIN THE JANUS KINASE FAMILY
1PKGB:589-924; B:589-924STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX
1T46A:589-924STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE
2Y4IB:666-928KSR2-MEK1 HETERODIMER
1XBAA:371-626CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN
1QPCA:245-494STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPDA:245-494STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPEA:245-494STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPJA:245-494CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE.
2OF2A:245-494CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 8 BOUND TO LCK
2OF4A:245-494CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 1 BOUND TO LCK
2OFUA:245-494X-RAY CRYSTAL STRUCTURE OF 2-AMINOPYRIMIDINE CARBAMATE 43 BOUND TO LCK
2OFVB:245-494; B:245-494CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK
2OG8B:245-494; B:245-494CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK
2PL0A:245-494LCK BOUND TO IMATINIB
2ZM1A:245-494CRYSTAL STRUCTURE OF IMIDAZO PYRAZIN 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
2ZM4A:245-494CRYSTAL STRUCTURE OF IMIDAZO QUINOXALINE 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
2ZYBA:245-494CRYSTAL STRUCTURE OF PHENYLIMIDAZO PYRAZIN 2 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3KMMA:245-494STRUCTURE OF HUMAN LCK KINASE WITH A SMALL MOLECULE INHIBITOR
3LCKA:245-494THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
3MPMA:245-494LCK COMPLEXED WITH A PYRAZOLOPYRIMIDINE
3S95B:339-604; B:339-604CRYSTAL STRUCTURE OF THE HUMAN LIMK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
2P0CB:587-854; B:587-854CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER
1R0PA:1078-1337CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH THE MICROBIAL ALKALOID K-252A
2RFNB:1078-1337; B:1078-1337X-RAY STRUCTURE OF C-MET WITH INHIBITOR.
2RFSA:1078-1337X-RAY STRUCTURE OF SU11274 BOUND TO C-MET
2WGJA:1078-1337X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET
2WKMA:1078-1337X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET
3LQ8A:1078-1337STRUCTURE OF THE KINASE DOMAIN OF C-MET BOUND TO XL880 (GSK1363089)
3Q6UA:1078-1337STRUCTURE OF THE APO MET RECEPTOR KINASE IN THE DUALLY-PHOSPHORYLATED, ACTIVATED STATE
3Q6WA:1078-1337STRUCTURE OF DUALLY-PHOSPHORYLATED MET RECEPTOR KINASE IN COMPLEX WITH AN MK-2461 ANALOG WITH SPECIFICITY FOR THE ACTIVATED RECEPTOR
3QTIB:1078-1337; B:1078-1337C-MET KINASE IN COMPLEX WITH NVP-BVU972
3RHKB:1078-1337; B:1078-1337CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF C-MET KINASE IN COMPLEX WITH ARQ 197
3PYYB:261-512; B:261-512DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE, SMALL-MOLECULE C-ABL KINASE ACTIVATOR THAT BINDS TO THE MYRISTOYL BINDING SITE
3OG7B:457-714; B:457-714B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX4032
3OMVB:349-606; B:349-606CRYSTAL STRUCTURE OF C-RAF (RAF-1)
2X2KA:724-1005CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X2LA:724-1005CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X2MB:724-1005; B:724-1005CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
3PLSA:1082-1341RON IN COMPLEX WITH LIGAND AMP-PNP
1KSWA:267-516STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) IN COMPLEX WITH N6-BENZYL ADP
1Y57A:267-516STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR
1YI6B:267-516; B:267-516C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533)
1YOJB:271-518; B:271-518CRYSTAL STRUCTURE OF SRC KINASE DOMAIN
1YOLB:269-518; B:269-518CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675
1YOMB:269-518; B:269-518CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A
2SRCA:267-516CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP
2OO8X:836-1092SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS
2OSCA:837-1092SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS
2P4IB:836-1092; B:836-1092EVOLUTION OF A HIGHLY SELECTIVE AND POTENT 2-(PYRIDIN-2-YL)-1,3,5-TRIAZINE TIE-2 KINASE INHIBITOR
2WQBA:824-1092STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A THIAZOLOPYRIMIDINE INHIBITOR
3L8PA:824-1092CRYSTAL STRUCTURE OF CYTOPLASMIC KINASE DOMAIN OF TIE2 COMPLEXED WITH INHIBITOR CEP11207
3LXNA:897-1169STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
3LXPA:897-1169STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
3NYXA:897-1169NON-PHOSPHORYLATED TYK2 JH1 DOMAIN WITH QUINOLINE-THIADIAZOLE-THIOPHENE INHIBITOR
3NZ0A:897-1169NON-PHOSPHORYLATED TYK2 KINASE WITH CMP6
1VR2A:834-1160HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN
1Y6AA:832-1158CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
1Y6BA:832-1158CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
1YWNA:832-1158VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO-FURO[2,3-D]PYRIMIDINE
2OH4A:832-1158CRYSTAL STRUCTURE OF VEGFR2 WITH A BENZIMIDAZOLE-UREA INHIBITOR
2P2HA:834-1160CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDINYL-TRIAZINE INHIBITOR
2QU5A:834-1160CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR
2QU6B:834-1160; B:834-1160CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
2XIRA:834-1160CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH PF-00337210 (N,2-DIMETHYL-6-(7-(2-MORPHOLINOETHOXY) QUINOLIN-4-YLOXY)BENZOFURAN-3-CARBOXAMIDE)
1U59A:338-593CRYSTAL STRUCTURE OF THE ZAP-70 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
2OZOA:338-593AUTOINHIBITED INTACT HUMAN ZAP-70
(-)
Mus musculus (Mouse) (15)
1OPJB:261-512; B:261-512STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
1OPKA:261-512STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
2QOHB:242-493; B:242-493CRYSTAL STRUCTURE OF ABL KINASE BOUND WITH PPY-A
2Z60A:242-493CRYSTAL STRUCTURE OF THE T315I MUTANT OF ABL KINASE BOUND WITH PPY-A
3K5VB:261-512; B:261-512STRUCTURE OF ABL KINASE IN COMPLEX WITH IMATINIB AND GNF-2
3KF4B:242-493; B:242-493STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
3KFAB:242-493; B:242-493STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
3MS9B:242-493; B:242-493ABL KINASE IN COMPLEX WITH IMATINIB AND A FRAGMENT (FRAG1) IN THE MYRISTATE POCKET
3MSSD:242-493; D:242-493; D:242-493; D:242-493ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE
3OXZA:242-493CRYSTAL STRUCTURE OF ABL KINASE DOMAIN BOUND WITH A DFG-OUT INHIBITOR AP24534
3OY3B:242-493; B:242-493CRYSTAL STRUCTURE OF ABL T315I MUTANT KINASE DOMAIN BOUND WITH A DFG-OUT INHIBITOR AP24589
1JPAB:637-896; B:637-896CRYSTAL STRUCTURE OF UNPHOSPHORYLATED EPHB2 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
2ZV7A:247-497LYN TYROSINE KINASE DOMAIN, APO FORM
2ZV8A:247-497LYN TYROSINE KINASE DOMAIN-AMP-PNP COMPLEX
2ZV9A:247-497LYN TYROSINE KINASE DOMAIN-PP2 COMPLEX
(-)
Rattus norvegicus (Rat) (2)
1K9AF:195-440; F:195-440; F:195-440; F:195-440; F:195-440; F:195-440CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
1LUFA:574-855CRYSTAL STRUCTURE OF THE MUSK TYROSINE KINASE: INSIGHTS INTO RECEPTOR AUTOREGULATION
(-)
Solanum pimpinellifolium (Currant tomato) (Lycopersicon pimpinellifolium) (1)
2QKWB:41-310STRUCTURAL BASIS FOR ACTIVATION OF PLANT IMMUNITY BY BACTERIAL EFFECTOR PROTEIN AVRPTO